The answer is yes, say agency scientists. Tomorrow's public meeting, which will last two days, will include a discussion on protecting patients from exposure to unnecessary radiation. According to the NYTimes, scientists plan on making their concerns known regarding how FDA ignored their warnings about using power CT scans to screen patients for colon cancer. The scientists say they'll be testifying that FDA managers brushed aside their warnings, which could have led to putting hundreds of patients in danger.